Time Course and Predictors of Health-Related Quality of Life Improvement and Medication Satisfaction in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder Treated with the Methylphenidate Transdermal System
- 1 October 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Child and Adolescent Psychopharmacology
- Vol. 20 (5), 355-364
- https://doi.org/10.1089/cap.2009.0092
Abstract
Objective: The aim of this study was to evaluate the time course and predictors of improvement in health-related quality of life (HRQL) and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder (ADHD) and treated with the methylphenidate transdermal system (MTS). Methods: Temporal relationships between ADHD symptoms, medication satisfaction, and HRQL measures were examined via latent growth curve, structural path, and growth mixture models. Results: Higher levels of medication satisfaction at the end of titration predicted greater increases in family HRQL (p = 0.004) and, to a lesser extent, child HRQL (p = 0.068) throughout the study. At 4 of 6 (p < 0.05) and 5 of 6 (p < 0.10) contemporaneous time points, ADHD symptoms predicted child HRQL. At 2 of 6 (p < 0.05) and 3 of 6 (p < 0.10) contemporaneous time points, ADHD symptoms predicted family HRQL. ADHD did not predict child or family HRQL improvements at subsequent time points. A uniform pattern of change for child HRQL was noted, with most HRQL change following the pattern of symptom change during titration. Three distinct patterns of change were noted for family HRQL. Conclusions: In most cases, medication satisfaction, ADHD symptoms, and HRQL improved simultaneously, suggesting that HRQL was not a delayed response to improvement in symptoms. Children showed a uniform pattern of improvement in HRQL that followed symptom change; three distinct patterns of change were found for improvement in family HRQL. Clinical Trial Registry: #NCT00151970.Keywords
This publication has 36 references indexed in Scilit:
- Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?Child and Adolescent Psychiatry and Mental Health, 2009
- HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal systemCurrent Medical Research and Opinion, 2009
- Practitioner Review: Quality of life in child mental health – conceptual challenges and practical choicesJournal of Child Psychology and Psychiatry, 2009
- Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: Reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the dayChild and Adolescent Psychiatry and Mental Health, 2008
- Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHDDevelopmental Medicine and Child Neurology, 2008
- Health-Related Quality of Life in Methylphenidate-Treated Children with Attention-Deficit–Hyperactivity Disorder: Results from a Taiwanese SampleAustralian & New Zealand Journal of Psychiatry, 2007
- Effectiveness of Atomoxetine and Quality of Life in Children with Attention-Deficit/Hyperactivity Disorder as Perceived by Patients, Parents, and Physicians in an Open-Label StudyJournal of Child and Adolescent Psychopharmacology, 2007
- A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)Current Medical Research and Opinion, 2007
- Atomoxetine in the Management of Children with ADHD: Effects on Quality of Life and School FunctioningClinical Pediatrics, 2006
- Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesStructural Equation Modeling: A Multidisciplinary Journal, 1999